Yue Lu

A novel disulfide bond-mediated cleavable RGD-modified PAMAM nanocomplex containing nuclear localization signal HMGB1 for enhancing gene transfection efficiency

Haiyang Hu, Dawei Chen, Ji Li, 2018, International journal of nanomedicine.

Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer

Xiufeng Pang, Zhenliang Sun, Kun Yuan, 2022, Acta pharmaceutica Sinica. B.

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.

M. Zelefsky, J. Reis-Filho, B. Weigelt, 2020, Journal of the National Cancer Institute.

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

M. Ladanyi, A. Drilon, M. Kris, 2020, Clinical Cancer Research.

Coupling EGFR-antagonistic affibody enhanced therapeutic effects of cisplatin liposomes in EGFR-expressing tumor models.

Yujiao Yang, Dianlong Jia, Fengjiao Yuan, 2021, Journal of pharmaceutical sciences.

Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer

Wenjun Jiang, Xin Wu, Qi Dai, 2018, International journal of nanomedicine.

Fusion of an EGFR-antagonistic affibody enhances the anti-tumor effect of TRAIL to EGFR positive tumors.

Renming Liu, Dianlong Jia, Fengjiao Yuan, 2022, International journal of pharmaceutics.

Tailored Polymers with Complement Activation Ability To Improve Antitumor Immunity.

M. Qiao, Haiyang Hu, Xiuli Zhao, 2019, Molecular pharmaceutics.

Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer

Wenjun Jiang, Xin Wu, Qi Dai, 2018, International journal of nanomedicine.

Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy.

Jianmei Wei, Xiaona Lu, Dianlong Jia, 2023, Journal of controlled release : official journal of the Controlled Release Society.